2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-103016
    WZ4141R
    		98.03%
    WZ4141R is an intermediate in the synthesis of compounds.
    WZ4141R
  • HY-50110
    Isopropyl 1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate
    		98.0%
    Isopropyl 1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate is a drug intermediate for synthesis of various active compounds.
    Isopropyl 1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate
  • HY-W006202
    BOC-(1S,3R)-3-aminocyclopentanecarboxylic acid
    		98.0%
    BOC-(1S,3R)-3-aminocyclopentanecarboxylic acid ((1S,3R)-3-[(tert-Butoxycarbonyl)amino]cyclopentanecarboxylic acid) is a synthetic intermediate useful for pharmaceutical synthesis.
    BOC-(1S,3R)-3-aminocyclopentanecarboxylic acid
  • HY-47241
    7-(Benzyloxy)-3,4-dihydronaphthalen-1(2H)-one
    		99.70%
    7-(Benzyloxy)-3,4-dihydronaphthalen-1(2H)-one is a drug intermediate for synthesis of various active compounds.
    7-(Benzyloxy)-3,4-dihydronaphthalen-1(2H)-one
  • HY-Z4460
    Anastrozole impurity 1
    		99.17%
    Anastrozole impurity 1 is an impurity of Anastrozole (HY-14274).
    Anastrozole impurity 1
  • HY-W250995
    Rebamipide impurity 13
    		98.27%
    Rebamipide impurity 13 is an impurity of Rebamipide (HY-B0360).
    Rebamipide impurity 13
  • HY-76200A
    voriconazole impurity 1
    		≥98.0%
    Voriconazole impurity 1 is an impurity of Voriconazole (HY-76200).
    voriconazole impurity 1
  • HY-W096115
    Mivacurium chloride impurity 6
    Mivacurium chloride impurity 6 is an impurity of Mivacurium chloride (HY-B1700A).
    Mivacurium chloride impurity 6
  • HY-W128579
    2-Pyrimidinepropanoic acid
    		Control
    2-Pyrimidinepropanoic acid is a synthetic intermediate useful for pharmaceutical synthesis.
    2-Pyrimidinepropanoic acid
  • HY-138181
    Contezolid phosphoramidic acid
    Contezolid phosphoramidic acid is an intermediate in the synthesis of proagents of antibacterial oxazolidinone agent MRX-I. Contezolid phosphoramidic acid is extracted from patent WO2015127316A1, Intermediate 3, Method I.
    Contezolid phosphoramidic acid
  • HY-133145
    hDDAH-1-IN-2
    hDDAH-1-IN-2 is a selective, orally active human dimethylarginine dimethylaminohydrolase-1 (hDDAH-1) inhibitor. hDDAH-1-IN-2 reveals an excellent profile regarding cell toxicity/viability.
    hDDAH-1-IN-2
  • HY-W017511R
    5,6-Dimethyl-1H-benzo[d]imidazole (Standard)
    5,6-Dimethyl-1H-benzo[d]imidazole (Standard) is the analytical standard of 5,6-Dimethyl-1H-benzo[d]imidazole (HY-W017511). This product is intended for research and analytical applications. 5,6-Dimethyl-1H-benzo[d]imidazole is an endogenous metabolite. 5,6-Dimethyl-1H-benzo[d]imidazole is also a benzimidazole derivative and can be used in the synthesis of other active compounds.
    5,6-Dimethyl-1H-benzo[d]imidazole (Standard)
  • HY-145578
    Linaprazan glurate
    		99.65%
    Linaprazan glurate (X842) is an orally atcive prodrug of Linaprazan (HY-100412) with a potent and prolonged inhibitory effect on gastric acid secretion. Linaprazan glurate is rapidly transformed by enzymatic cleavage into its active metabolite, linaprazan. Linaprazan glurate is a potassium-competitive acid blocker. Linaprazan glurate selectively inhibites acid formation from gastric H⁺/K⁺-ATPase in a potassium-dependent manner (IC50 = 436.2 nM). Linaprazan glurate can be used for the studies of erosive esophagitis (EE).
    Linaprazan glurate
  • HY-169435
    TK-OH
    		98.36%
    TK-OH is the linker of LTB (HY-169434). TK-OH can be used for the research of cancers.
    TK-OH
  • HY-W006448
    5-Ethoxy-4-methyloxazole
    5-Ethoxy-4-methyloxazole
    5-Ethoxy-4-methyloxazole
  • HY-135208
    tert-Butyl 2-(5-chloro-2,2'-dioxospiro[indole-3,3'-pyrrolidine]-1-yl)acetate
    tert-Butyl 2-(5-chloro-2,2'-dioxospiro[indole-3,3'-pyrrolidine]-1-yl)acetate is an intermediate used in the synthesis of potent DP2 receptor antagonists based on a novel spiro-indolinone compound.
    tert-Butyl 2-(5-chloro-2,2'-dioxospiro[indole-3,3'-pyrrolidine]-1-yl)acetate
  • HY-W015301S
    Dimethyl adipate-d4
    Dimethyl adipate-d4 (Hexanedioic acid dimethyl ester-d4) is the deuterium labeled Dimethyl adipate (HY-W015301). Dimethyl adipate is an aliphatic dicarboxylate compound. Dimethyl adipate is mainly used as a plasticizer and an intermediate in organic synthesis.
    Dimethyl adipate-d<sub>4</sub>
  • HY-178290
    MC-Gly-Gly-Phe-Exatecan analog 38
    MC-Gly-Gly-Phe-Exatecan analog 38 (Compound L-II-4) is part of an antibody-drug conjugate (ADC), consisting of an ADC toxicant molecule and an ADC linker. MC-Gly-Gly-Phe-Exatecan analog 38 can be used to synthesize ADCs (such as ADC-II-15 and ADC-III-13). MC-Gly-Gly-Phe-Exatecan analog 38 can also be used in cancer research (ADC Cytotoxin: HY-178315, ADC Linker: HY-44235).
    MC-Gly-Gly-Phe-Exatecan analog 38
  • HY-W010321R
    Furfuryl acetate (Standard)
    Tetracaine (Standard) is the analytical standard of Tetracaine. This product is intended for research and analytical applications. 0
    Furfuryl acetate (Standard)
  • HY-164512
    NRMA-I
    NRMA-I is the amide produrg of the small molecule nuclear receptor modulator. NRMA-I exhibits a higher exposure in the brain, indicating that a good blood-brain barrier (BBB) penetration. NRMA-I can be used for research of central nervous system diseases related to nuclear receptors, such as Alzheimer's disease and Parkinson's disease.
    NRMA-I